chronic
lung
diseas
chronic
obstruct
pulmonari
diseas
copd
asthma
cystic
fibrosi
cf
interstiti
lung
diseas
ild
affect
mani
individu
worldwid
patient
chronic
lung
diseas
suscept
respiratori
lung
infect
viral
infect
contribut
diseas
pathogenesi
review
highlight
associ
lung
infect
respect
chronic
lung
diseas
infect
differ
lung
diseas
affect
diseas
exacerb
progress
copd
one
lead
caus
mortal
morbid
worldwid
among
sever
risk
factor
cigarett
smoke
import
one
howev
smoke
alon
explain
aspect
copd
copd
develop
even
nonsmok
especi
context
biomass
exposur
part
world
half
smoker
develop
copd
subset
patient
copd
exhibit
persist
inflamm
despit
smoke
cessat
addit
acceler
loss
lung
function
may
occur
independ
smoke
occur
acut
copd
exacerb
import
elucid
addit
contribut
factor
besid
smoke
control
diseas
copd
character
chronic
inflamm
small
airway
respiratori
tract
infect
import
caus
acut
exacerb
progress
diseas
common
viral
infect
chronic
obstruct
pulmonari
diseas
exacerb
histor
bacteria
consid
main
infecti
caus
copd
exacerb
grow
bodi
evid
howev
implic
viral
upper
respiratori
tract
infect
uri
predomin
risk
factor
associ
exacerb
copd
approxim
copd
exacerb
associ
upper
respiratori
infect
uri
viral
infect
suggest
import
contributor
copd
exacerb
fact
shown
respiratori
virus
includ
rhinoviru
influenza
respiratori
syncyti
viru
rsv
caus
copd
exacerb
exacerb
sever
last
longer
associ
heighten
airway
system
inflammatori
respons
exacerb
due
nonvir
caus
differ
attribut
sole
pulmonari
structur
alter
patient
copd
healthi
smoker
also
experi
exagger
symptomat
respons
viral
infect
detect
rate
viru
copd
exacerb
variabl
approxim
detect
rate
depend
onset
present
type
sampl
season
commonli
identifi
virus
exacerb
copd
includ
rhinoviru
influenza
virus
rsv
parainfluenza
adenoviru
metapneumoviru
coronaviru
among
rhinoviru
metapneumoviru
common
viral
pathogen
studi
use
polymeras
chain
reaction
pcr
studi
rhinoviru
detect
event
copd
acut
exacerb
influenza
vaccin
rate
also
affect
preval
hong
kong
studi
show
influenza
common
viru
hospit
patient
copd
meanwhil
cohort
london
outpati
clinic
show
low
preval
due
rel
high
influenza
vaccin
rate
mani
copd
exacerb
also
includ
viru
bacteria
coinfect
approxim
hospit
patient
copd
exacerb
show
coinfect
clinic
impact
coinfect
longer
hospit
stay
sever
function
impair
symptom
copd
exacerb
includ
cough
increas
sputum
volum
purul
dyspnea
howev
easi
differenti
viral
nonvir
caus
copd
exacerb
symptom
typic
commoncold
symptom
includ
fever
nasal
congest
rhinorrhea
preval
patient
copd
viru
detect
symptom
also
note
nonvir
exacerb
use
diagnosi
remain
limit
sputum
purul
suggest
evid
bacteri
infect
copd
exacerb
sputum
also
purul
due
neutrophilia
irrespect
causal
organ
furthermor
almost
copd
exacerb
mark
chang
sputum
characterist
therefor
sputum
characterist
use
marker
differenti
viral
bacteri
infect
hand
sputum
purul
may
use
decid
usag
antibiot
although
neutrophil
predominantli
increas
cell
type
sputum
copd
exacerb
one
report
show
increas
eosinophilia
viral
exacerb
viral
exacerb
also
associ
frequent
exacerb
sever
exacerb
prolong
time
symptom
recoveri
virus
also
detect
stabl
copd
patient
rsv
infect
higher
plasma
fibrinogen
serum
interleukin
il
hypercapnia
stabl
state
suggest
asymptomat
viral
colon
potenti
role
chronic
inflamm
diseas
progress
copd
anoth
studi
support
show
relationship
frequent
rsv
detect
acceler
lung
function
declin
mli
vs
mli
p
propos
alveolar
epitheli
cell
smoker
patient
sever
emphysema
frequent
latent
infect
adenoviru
compar
smoker
without
airflow
obstruct
found
copd
lung
epitheli
cell
express
adenovir
protein
associ
specif
lung
inflamm
investig
propos
adenovir
infect
patient
copd
contribut
amplif
lung
inflammatori
respons
pcr
respiratori
sampl
main
tool
detect
causal
virus
widespread
use
pcr
techniqu
low
virusdetect
rate
underestim
role
copd
introduct
pcr
help
revolution
viral
diagnost
pcr
far
sensit
equal
specif
tradit
techniqu
includ
cultur
antigendetect
test
serolog
rhinoviru
one
common
virus
copd
exacerb
difficult
cultur
serolog
possibl
due
presenc
serotyp
without
pcr
virus
identifi
result
earli
studi
use
diagnost
method
underestim
preval
rhinoviru
among
variou
method
obtain
sampl
nasal
lavag
throat
swab
induc
sputum
yet
evid
method
superior
virus
especi
rsv
directli
invad
lower
respiratori
tract
therefor
obtain
simultan
lower
respiratori
tract
sampl
increas
sensit
assay
big
challeng
molecular
diagnost
approach
discrimin
caus
organ
colon
antivir
therapi
necessari
immunocompet
asymptomat
patient
copd
antivir
therapi
indic
sole
basi
known
diagnosi
copd
endem
viral
infect
selflimit
pharmacolog
manag
necessari
case
sever
progress
pandem
influenza
viru
oseltamivir
indic
clinic
diagnosi
made
one
difficult
decis
prescrib
antibiot
necessari
caus
organ
viru
antibiot
usual
necessari
unless
one
concern
postvir
secondari
bacteri
lung
infect
although
sputum
characterist
indic
caus
organ
sputum
purul
suggest
decid
usag
antibiot
influenza
vaccin
highli
recommend
patient
copd
chronic
lung
diseas
asthma
defin
revers
airflow
obstruct
bronchial
hyperrespons
underli
inflamm
asthma
continu
seriou
global
health
problem
age
group
preval
still
increas
mani
countri
worldwid
asthma
affect
approxim
million
peopl
increas
incid
develop
world
develop
inhal
medic
hospit
mortal
decreas
overal
asthma
control
remain
suboptim
mani
studi
support
evid
viral
infect
sever
import
role
diseas
develop
exacerb
progress
hygien
hypothesi
propos
lower
incid
infect
earli
childhood
explain
rise
allerg
diseas
asthma
thought
repeat
exposur
infect
associ
healthier
immun
system
protect
allerg
autoimmun
diseas
specif
microb
encount
could
elicit
thelper
type
h
immun
respons
could
downregul
thelper
type
h
immun
respons
favor
asthma
develop
hygien
hypothesi
focus
lack
h
stimul
caus
overact
h
respons
could
lead
allerg
immun
respons
role
virus
play
h
respons
long
debat
studi
whether
earli
viral
infect
set
motion
h
immun
respons
whether
lack
h
respons
caus
symptomat
respons
viral
infect
unclear
similarli
debat
whether
asthma
exacerb
result
immunedefici
respons
exagger
immun
respons
continu
mani
studi
support
evid
viral
infect
sever
import
role
diseas
develop
exacerb
progress
viral
infect
close
associ
wheez
episod
resembl
manifest
asthma
especi
younger
group
episod
relat
later
develop
asthma
among
virus
caus
respiratori
infect
rsv
rhinoviru
welldocu
increas
risk
asthma
though
earli
adulthood
longitudin
studi
sever
earli
rsv
bronchiol
associ
increas
preval
allerg
asthma
persist
childhood
even
earli
adulthood
among
viral
wheez
ill
infanc
earli
childhood
caus
rsv
infect
signific
predictor
subsequ
develop
asthma
host
factor
may
also
affect
pathogenesi
asthma
connect
virus
children
wheez
ill
rhinoviru
associ
asthma
develop
certain
variant
chromosom
asthma
exacerb
may
trigger
respiratori
infect
well
atmospher
domiciliari
environment
factor
viral
infect
may
caus
loss
asthma
control
exacerb
particularli
children
allerg
asthma
coincid
respiratori
viral
infect
studi
asthma
exacerb
show
higher
virusdetect
rate
copd
pcr
show
presenc
virus
children
adult
common
virus
includ
rhinoviru
influenza
rsv
corona
viru
although
season
variat
present
patient
asthma
uri
symptom
persist
longer
sever
healthi
control
like
copd
pcr
respiratori
sampl
prefer
diagnost
modal
use
pcr
technolog
etiolog
respiratori
infect
establish
viral
cultur
difficult
perform
pcr
show
high
sensit
specif
although
may
quantit
case
mani
studi
attempt
find
patholog
immun
respons
virus
caus
exacerb
mechan
exacerb
remain
poorli
understood
clear
asthma
exacerb
trigger
virus
manifest
impair
overact
immun
respons
evid
h
pathway
caus
downregul
antivir
interferon
ifn
b
ifnl
higher
viral
load
vitro
howev
reproduc
vivo
studi
hand
evid
suggest
increas
h
cytokin
chemokin
produc
respons
viral
ill
activ
inflammatori
cascad
thought
associ
asthma
exacerb
inhal
corticosteroid
ic
commonli
use
treatment
asthma
treatment
continu
case
viral
infect
pretreat
ic
shown
improv
airway
hyperrespons
eosinophil
inflamm
patient
atop
asthma
experiment
infect
rhinoviru
acut
exacerb
oral
intraven
iv
corticosteroid
usual
indic
immunosuppress
function
medic
preclud
use
viral
infecti
exacerb
viral
infect
selflimit
therefor
antivir
medic
necessari
except
sever
epidem
case
influenza
vaccin
recommend
influenza
caus
asthma
exacerb
howev
avail
evid
suffici
assert
vaccin
reduc
frequenc
sever
asthma
exacerb
cf
common
fatal
genet
diseas
unit
state
patient
live
cf
unit
state
cf
autosom
recess
disord
caus
mutat
cf
transmembran
conduct
regul
gene
cftr
lead
abnorm
epitheli
chlorid
transport
caus
multiorgan
dysfunct
lung
particularli
affect
evid
chronic
inflamm
recurr
infect
impair
mucociliari
clearanc
innat
immun
impair
directli
affect
host
defens
respiratori
pathogen
pulmonari
infect
remain
greatest
caus
morbid
mortal
lead
prematur
death
cf
similar
individu
without
cf
viral
respiratori
infect
common
cf
varieti
studi
date
report
variabl
incid
common
respiratori
pathogen
includ
influenza
b
rsv
parainfluenza
viru
piv
rhinoviru
metapneumoviru
coronaviru
adenoviru
studi
incid
specif
viral
isol
vari
greatli
one
studi
next
due
multipl
factor
includ
methodolog
season
variat
geograph
locat
differ
age
group
recent
studi
adult
cf
follow
prospect
month
rhinoviru
account
confirm
viral
infect
follow
metapneumoviru
adenoviru
unlik
previou
studi
influenza
viru
b
piv
rsv
togeth
account
viral
isol
previou
studi
shown
individu
cf
suscept
viral
infect
healthi
control
prospect
studi
schoolag
individu
cf
compar
agematch
control
differ
frequenc
culturedocu
seroposit
viral
infect
younger
patient
higher
incid
viral
infect
group
howev
translat
acceler
lung
function
declin
patient
cf
later
studi
evalu
impact
viral
infect
pulmonari
function
infant
cf
similarli
show
differ
incid
viral
infect
howev
infant
cf
increas
frequenc
respiratori
symptom
wherea
control
demonstr
associ
respiratori
ill
lung
function
infant
cf
suffer
rsv
infect
develop
respiratori
symptom
reduct
lung
function
prospect
studi
examin
impact
rsv
infect
lung
function
pediatr
popul
demonstr
subject
cf
increas
frequenc
respiratori
symptom
despit
similar
rate
viral
isol
cultur
serolog
healthi
control
investig
demonstr
clear
associ
rsv
infect
worsen
clinic
sever
score
lung
function
measur
rate
durat
hospit
respiratori
exacerb
cf
respiratori
exacerb
acut
clinic
deterior
patient
clinic
condit
character
increas
respiratori
symptom
sputum
product
declin
lung
function
exacerb
commonli
precipit
acquisit
new
organ
chang
respiratori
flora
cf
pulmonari
exacerb
rate
increas
winter
link
influenza
season
virus
frequent
implic
caus
respiratori
symptom
cf
includ
rhinoviru
rsv
adenoviru
piv
influenza
b
metapneumoviru
viral
infect
frequent
detect
cf
exacerb
viral
detect
improv
signific
leap
diagnost
technolog
implement
quantit
realtim
pcr
studi
viral
detect
cf
popul
achiev
highest
detect
rate
compar
exist
literatur
previous
reli
serolog
test
viral
isol
identif
respiratori
viru
exacerb
purport
clinic
deterior
increas
durat
iv
antibiot
compar
virusneg
exacerb
studi
children
cf
respiratori
exacerb
posit
viral
isol
two
studi
adult
patient
cf
report
viral
isol
rate
exacerb
n
n
although
virusposit
exacerb
associ
higher
respiratori
symptom
score
serum
biomark
inflamm
viral
infect
increas
rate
lung
function
declin
compar
virusneg
exacerb
similarli
signific
associ
viral
infect
acceler
lung
function
declin
longterm
followup
recent
studi
combin
pediatr
adult
popul
report
even
higher
incid
virusposit
exacerb
adult
children
rsv
common
caus
lower
respiratori
tract
infect
young
children
children
cf
rsv
influenza
shown
signific
effect
lung
function
infant
cf
rsv
infect
account
onethird
hospit
respiratori
failur
chronic
supplement
oxygen
requir
follow
year
addit
rsv
influenza
b
infect
detect
cf
exacerb
influenza
also
associ
acut
sustain
declin
lung
function
well
respiratori
failur
subsequ
supplement
oxygen
requir
studi
pediatr
patient
influenza
virusposit
exacerb
larger
declin
lung
function
vs
virus
addit
influenza
infect
frequent
associ
larger
drop
forc
expiratori
volum
second
fev
viral
infect
accord
data
european
cystic
fibrosi
societi
influenza
pandem
sever
impact
adult
pediatr
patient
cf
preval
infect
among
center
multipl
countri
rang
among
case
report
incid
exacerb
patient
requir
hospit
requir
supplement
oxygen
incid
respiratori
failur
fatal
patient
advanc
lung
diseas
like
suffer
sever
clinic
cours
interestingli
patient
recov
lung
function
preinfect
valu
rhinoviru
increasingli
report
signific
pathogen
cf
popul
rhinoviru
associ
increas
respiratori
symptom
lung
function
declin
frequenc
exacerb
may
due
improv
detect
techniqu
inclus
recent
detect
speci
rhinoviru
c
clinic
signific
viral
infect
cf
extend
beyond
immedi
morbid
viral
infect
propos
play
role
new
bacteri
acquisit
worsen
clinic
outcom
new
acquisit
pseudomona
aeruginosa
cf
associ
winter
month
coincid
peak
respiratori
viral
infect
propos
rsv
could
facilit
initi
infect
cf
airway
p
aeruginosa
howev
studi
adult
cf
show
chang
sputum
densiti
p
aeruginosa
concurr
viral
infect
present
retrospect
studi
older
patient
chronic
p
aeruginosa
infect
report
acut
deterior
clinic
statu
associ
influenza
viru
infect
punch
colleagu
use
multiplex
reversetranscriptas
pcr
rtpcr
assay
combin
enzymelink
amplicon
hybrid
assay
elaha
identif
common
respiratori
virus
sputum
patient
cf
fiftythre
sputum
sampl
collect
season
sampl
patient
posit
respiratori
viru
influenza
b
parainfluenza
type
influenza
rsv
statist
associ
viru
statu
demograph
clinic
variabl
isol
rate
p
aeruginosa
staphylococcu
aureu
aspergillu
fumigatu
retrospect
studi
older
patient
chronic
p
aeruginosa
infect
report
acut
deterior
clinic
statu
associ
influenza
viru
infect
pulmonari
fibrosi
end
stage
sever
diffus
parenchym
lung
diseas
character
excess
matrix
deposit
lung
parenchym
destruct
progress
respiratori
insuffici
idiopath
pulmonari
fibrosi
ipf
form
pulmonari
fibrosi
overal
poor
surviv
rate
etiolog
remain
poorli
understood
sever
risk
predispos
factor
pulmonari
fibrosi
includ
environment
tobacco
smoke
viral
infect
famili
histori
genet
pulmonari
fibrosi
character
progress
lung
declin
time
mani
patient
experienc
diseas
stabil
punctuat
episod
acut
worsen
clinic
symptom
radiograph
chang
chest
imag
acut
exacerb
pulmonari
fibrosi
defin
obviou
identifi
caus
found
pulmonari
worsen
patient
ipf
develop
acut
exacerb
year
result
death
howev
unclear
exacerb
truli
acceler
underli
fibrot
prolif
process
pulmonari
fibrosi
due
complic
infect
given
ipf
exacerb
often
accompani
cough
fever
initi
suspect
respiratori
virus
like
caus
ipf
exacerb
compar
strong
associ
virus
exacerb
obstruct
lung
diseas
asthma
copd
current
littl
research
suggest
possibl
caus
exacerb
ipf
sever
investig
role
pulmonari
virus
acut
exacerb
result
howev
mix
result
gene
express
analys
stabl
ipf
versu
exacerb
patient
ipf
find
evid
infecti
overwhelm
inflammatori
etiolog
although
antimicrobi
peptid
alpha
defens
found
increas
epithelium
peripher
blood
use
multiplex
pcr
panvir
microarray
discoveri
platform
nextgener
deep
sequenc
increas
viral
detect
sensit
viral
infect
detect
case
acut
ipf
exacerb
four
patient
ipf
acut
exacerb
evid
common
respiratori
viral
infect
rhinoviru
coronaviru
parainfluenza
wherea
virus
detect
bronchoalveolar
lavag
fluid
stabl
patient
interestingli
torqu
teno
viru
ttv
rel
new
singlestrand
dna
viru
found
common
patient
acut
exacerb
stabl
control
howev
ttv
also
detect
patient
acut
respiratori
distress
syndrom
suggest
viru
specif
ipf
deep
sequenc
lung
patient
acut
exacerb
ipf
reveal
evid
viral
pathogen
whether
viral
infect
truli
major
role
ipf
pathogenesi
remain
unclear
although
evid
suggest
case
given
studi
thu
far
still
possibl
viral
associ
clearli
proven
due
time
sampl
ipf
patient
exacerb
possibl
incorrect
compart
sampl
identifi
virus
bronchoalveolar
fluid
vs
interstiti
diseas
gene
express
studi
lung
tissu
show
suggest
type
ii
alveolar
epitheli
cell
injuri
prolifer
endotheli
cell
injuri
coagul
patient
acut
exacerb
ipf
distinct
patient
acut
lung
injuri
possibl
major
associ
convent
respiratori
virus
ipf
howev
report
presenc
certain
human
herpesvirus
epsteinbarr
viru
ebv
patient
ipf
anim
model
fibrosi
anoth
studi
show
patient
ipf
underw
lung
transplant
found
posit
ebv
human
herpesviru
hhv
compar
control
lung
sampl
posit
neg
ebv
suggest
herpesvirus
could
contribut
lung
epitheli
injuri
initi
profibrot
respons
ipf
whether
ipf
acut
exacerb
repres
reactiv
latent
herpesvirus
remain
unknown
requir
explor
interest
evid
associ
respiratori
virus
ipf
rather
weak
wherea
quit
clear
respiratori
viral
infect
import
pathogenesi
obstruct
lung
diseas
copd
asthma
differ
associ
respiratori
viru
chronic
lung
diseas
due
involv
differ
cell
type
lung
airway
epithelium
versu
alveolar
epithelium
understand
mechan
behind
differ
import
determin
sarcoidosi
system
inflammatori
diseas
character
noncas
epithelioid
granulomat
inflamm
affect
site
includ
lung
although
mani
patient
experi
diseas
remiss
within
first
year
patient
develop
chronic
diseas
requir
treatment
prevent
progress
organ
dysfunct
fibrot
chang
epidemiolog
studi
basic
research
suggest
sarcoidosi
repres
immun
respons
exogen
agent
genet
suscept
individu
definit
exogen
agent
respons
sarcoidosi
remain
elus
investig
specul
transmiss
infecti
agent
may
caus
sarcoidosi
increas
bodi
evid
suggest
link
infect
sarcoidosi
especi
regard
mycobacteria
propionibacteria
thought
mayb
persist
antigen
stimul
microbi
agent
site
inflamm
result
sarcoidosi
howev
date
identifi
etiolog
sarcoidosi
remain
elus
varieti
virus
propos
etiolog
agent
trigger
sarcoidosi
yet
associ
difficult
defin
virus
associ
sarcoidosi
base
serolog
includ
ebv
cytomegaloviru
herp
simplex
coxsacki
viru
data
support
increas
frequenc
viral
respiratori
infect
sarcoidosi
lack
respiratori
virus
remain
import
pathogenesi
chronic
lung
diseas
recent
data
use
sensit
nucleic
acidbas
viral
diagnost
highlight
underappreci
preval
respiratori
virus
role
lung
diseas
evid
contribut
diseas
pathogenesi
exacerb
compel
chronic
lung
diseas
copd
asthma
cf
virus
commonli
found
associ
diseas
exacerb
much
less
compel
evid
associ
virus
ipf
sarcoidosi
measur
better
understand
respiratori
viral
infect
contribut
diseas
pathogenesi
mani
chronic
lung
diseas
need
prevent
measur
limit
viral
infect
good
hand
hygien
avoid
sick
contact
viral
vaccin
recommend
patient
suffer
chronic
lung
diseas
